Top

Reactions Weekly

Published in:

01-01-2023 | Kidney Injury | Case report

Ruxolitinib

Acute reversible kidney injury, pulmonary oedema and shortness of breath: case report

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Kirkham Z, et al. A single centre experience of ruxolitinib for treatment of steroid refractory chronic graft versus host disease. Bone Marrow Transplantation 57 (Suppl. 1): 215 (plus poster) abstr. P211, et al. Nov 2022. Available from: URL: http://doi.org/10.1038/s41409-022-01798-0 [abstract]

Title: Ruxolitinib
Acute reversible kidney injury, pulmonary oedema and shortness of breath: case report
Publication date: 01-01-2023
Publisher: Springer International Publishing
Keywords: Kidney Injury
Graft-Versus-Host Disease
Graft-Versus-Host Disease
Ruxolitinib
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-31287-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Ruxolitinib

Acute reversible kidney injury, pulmonary oedema and shortness of breath: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Amantadine/haloperidol/quetiapine

Antiepileptic-drugs

Azathioprine/prednisone

Dabigatran etexilate/warfarin

Insulin/simvastatin

Ad26.cov2-s/elasomeran/tozinameran